Opportunity Information: Apply for PAR 23 186
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, is seeking proposals under the Alcohol Health Services Research (R34 Clinical Trial Optional) funding opportunity (PAR 23-186). This grant is designed to support early, developmental work in alcohol health services research with the overarching goal of closing the treatment gap for people with alcohol use disorder (AUD). In practical terms, the program is aimed at improving how AUD care is reached, delivered, paid for, implemented, and tailored so that more people who need effective services are able to get them and stick with them.
The opportunity is centered on five main research emphasis areas. First, it prioritizes studies that increase access to AUD treatment, which can include research on overcoming barriers such as limited provider availability, geographic challenges, fragmented referral pathways, and difficulties integrating AUD services into common entry points like primary care or community settings. Second, it encourages work that makes treatment more appealing to individuals with AUD, recognizing that uptake depends not only on availability but also on how acceptable, convenient, culturally responsive, and person-centered the services feel to potential patients. Third, it calls for research examining cost structures and insurance systems, reflecting the reality that payment models, reimbursement rules, coverage limitations, and administrative burdens can strongly shape whether evidence-based AUD care is offered and sustained. Fourth, it supports dissemination and implementation studies focused on existing evidence-based approaches for treating AUD, meaning projects can examine how proven interventions are adopted in real-world settings, what prevents or enables faithful delivery, and what strategies help scale effective care across systems. Fifth, the NOFO highlights reducing health disparities as a direct strategy for closing the AUD treatment gap, encouraging applicants to address inequities experienced by health disparity populations and to develop or test approaches that improve reach and outcomes for groups who have historically faced barriers to care.
The funding instrument is a discretionary grant, and the activity area is health (CFDA 93.273). The mechanism is R34, and clinical trials are optional, meaning applicants may propose studies that do or do not involve a clinical trial depending on the research question and design. The announcement was created on May 15, 2023, with an original closing date of July 18, 2023, indicating a defined submission window for that cycle.
Eligibility is broad and includes many types of organizations that are positioned to conduct health services research or partner with service systems. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other categories. The NOFO also explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, non-U.S. entities (foreign organizations), and U.S. territories or possessions. This wide eligibility reflects an intent to encourage participation from a range of research, healthcare, and community organizations, including those serving populations most affected by treatment access gaps and health disparities.
Overall, this opportunity supports research that helps translate what is known to work for AUD into real-world systems, while also addressing the financial and structural conditions that determine whether patients can actually receive those services. The emphasis on access, acceptability, financing, implementation, and disparities signals that NIAAA is looking for projects that can realistically move the needle on treatment reach and equity, not just demonstrate efficacy in ideal conditions.Apply for PAR 23 186
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2023-05-15.
- Applicants must submit their applications by 2023-07-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): NIAAA Alcohol Health Services Research (R34 Clinical Trial Optional) - PAR 23-186
1) What is this funding opportunity?
This opportunity is the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Alcohol Health Services Research grant using the R34 mechanism (Clinical Trial Optional) under Funding Opportunity PAR 23-186. It supports early, developmental work in alcohol health services research.
2) What is the overall purpose of this grant program?
The overarching goal is to help close the treatment gap for people with alcohol use disorder (AUD). In practice, the program is focused on improving how AUD care is reached, delivered, paid for, implemented, and tailored so more people who need effective services can access them and stay engaged.
3) What kinds of research does NIAAA want to support through this program?
The program targets alcohol health services research, especially studies that address real-world systems and conditions affecting AUD care. The emphasis is on research that can realistically improve treatment reach and equity (not just show efficacy under ideal conditions).
4) What are the main research emphasis areas?
The opportunity highlights five primary emphasis areas:
- Increasing access to AUD treatment
- Making AUD treatment more appealing/acceptable to people with AUD
- Examining cost structures and insurance/payment systems that influence care
- Dissemination and implementation research for evidence-based AUD approaches
- Reducing health disparities as a strategy to close the AUD treatment gap
5) What does "increasing access to AUD treatment" mean in this NOFO?
It includes research on overcoming barriers that keep people from obtaining treatment, such as limited provider availability, geographic challenges, fragmented referral pathways, and difficulties integrating AUD services into common entry points like primary care or community settings.
6) What does the NOFO mean by making treatment "more appealing"?
It recognizes that treatment uptake depends on more than availability. The NOFO encourages research that improves how acceptable, convenient, culturally responsive, and person-centered services feel to individuals with AUD.
7) Why does this opportunity include cost, insurance, and payment model research?
Because financing and administrative realities strongly shape whether evidence-based AUD care is offered and sustained. The NOFO specifically points to payment models, reimbursement rules, coverage limitations, and administrative burdens as factors that can influence access and continuity of care.
8) What is meant by "dissemination and implementation" research in this program?
This refers to studying how existing evidence-based AUD interventions are adopted and delivered in real-world settings. Projects can examine what prevents or enables faithful delivery and what strategies help scale effective care across systems.
9) How does the NOFO address health disparities?
Reducing health disparities is explicitly framed as a direct strategy to close the AUD treatment gap. The NOFO encourages applicants to address inequities experienced by health disparity populations and to develop or test approaches that improve reach and outcomes for groups that have historically faced barriers to care.
10) What grant mechanism is being used?
The mechanism is R34, which is described as supporting early, developmental work in alcohol health services research.
11) Are clinical trials required?
No. The opportunity is listed as "Clinical Trial Optional," meaning applicants may propose studies with or without a clinical trial, depending on the research question and design.
12) What federal agency is offering this grant?
The grant is offered by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), which is part of the National Institutes of Health (NIH).
13) What is the assistance listing / CFDA number and program area?
The activity area is Health, and the CFDA (assistance listing) number provided is 93.273.
14) What type of funding instrument is this?
The funding instrument is a discretionary grant.
15) Who is eligible to apply?
Eligibility is broad and includes many types of organizations positioned to conduct health services research or partner with service systems. Eligible applicants include:
- State, county, city, township, and special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Tribal organizations that are not federally recognized tribal governments
- Public housing authorities and Indian housing authorities
- Nonprofits with or without 501(c)(3) status (other than institutions of higher education)
- For-profit organizations other than small businesses
- Small businesses
- Other categories referenced in the NOFO
16) Are minority-serving institutions and community organizations eligible?
Yes. The NOFO explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations.
17) Are federal agencies eligible to apply?
Yes. The NOFO explicitly includes eligible federal agencies as eligible applicants.
18) Are non-U.S. (foreign) organizations eligible?
Yes. The NOFO explicitly mentions non-U.S. entities (foreign organizations) as eligible applicants.
19) Are U.S. territories or possessions eligible?
Yes. The NOFO explicitly includes U.S. territories or possessions.
20) What is the official program name and identifier?
The opportunity is titled Alcohol Health Services Research (R34 Clinical Trial Optional) and is identified as PAR 23-186.
21) When was this opportunity created and what was the closing date for the noted cycle?
The announcement was created on May 15, 2023, and the original closing date listed is July 18, 2023, indicating a defined submission window for that cycle.
22) What kinds of barriers to treatment does this program consider important to address?
Examples stated in the NOFO description include limited provider availability, geographic challenges, fragmented referral pathways, and difficulties integrating AUD services into common entry points like primary care or community settings.
23) Does this program focus only on discovering new AUD treatments?
The emphasis described is on translating what is known to work for AUD into real-world systems, including improving access, acceptability, financing, implementation, and reducing disparities. It prioritizes moving evidence-based care into routine practice conditions rather than focusing only on efficacy in ideal conditions.
24) What is meant by improving how AUD care is "reached, delivered, paid for, implemented, and tailored"?
Based on the description provided, this means studying and improving the service system factors that affect whether people can find AUD care, receive it in settings they actually use, have it covered and reimbursed in sustainable ways, ensure interventions are adopted and delivered effectively, and tailor services to be person-centered and responsive to different populations and contexts.
Browse more opportunities from the same category: Health
Next opportunity: NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional)
Previous opportunity: Scaling the U.S. Solar Manufacturing Workforce RFI
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 186
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 186) also looked into and applied for these:
| Funding Opportunity |
|---|
| Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) Apply for PAR 23 187 Funding Number: PAR 23 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) Apply for RFA NS 24 010 Funding Number: RFA NS 24 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Treatment and Recovery Research (R34 Clinical Trial required) Apply for PAR 23 188 Funding Number: PAR 23 188 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 029 Funding Number: RFA AI 23 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional) Apply for RFA NS 23 027 Funding Number: RFA NS 23 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 021 Funding Number: RFA AG 24 021 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed) Apply for RFA AI 23 032 Funding Number: RFA AI 23 032 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 023 Funding Number: RFA AG 24 023 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 022 Funding Number: RFA AG 24 022 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)? Apply for RFA AG 24 038 Funding Number: RFA AG 24 038 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)? Apply for RFA AG 24 036 Funding Number: RFA AG 24 036 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Health Information Systems (HIS) Activity Apply for 72052123RFI00001 Funding Number: 72052123RFI00001 Agency: Haiti USAID-Port Au Prince Category: Health Funding Amount: Case Dependent |
| Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed) Apply for RFA NS 24 003 Funding Number: RFA NS 24 003 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed) Apply for PAR 23 211 Funding Number: PAR 23 211 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) Apply for PAR 23 212 Funding Number: PAR 23 212 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional) Apply for RFA MD 23 011 Funding Number: RFA MD 23 011 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Accelerating Behavioral and Social Science through Ontology Development and Use: Dissemination and Coordination Center (U24) Clinical Trial Not Allowed Apply for PAR 23 181 Funding Number: PAR 23 181 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 23 001 Funding Number: RFA AA 23 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) Apply for RFA AA 23 002 Funding Number: RFA AA 23 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required) Apply for PAR 23 209 Funding Number: PAR 23 209 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 186", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.